Previous 10 | Next 10 |
SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced that Matthew J. D’...
2024-03-14 21:33:12 ET Evoke Pharma, Inc. (EVOK) Q4 2023 Results Conference Call March 14, 2024 04:30 PM ET Company Participants Daniel Kontoh-Boateng - Investor Relations David Gonyer - Co-Founder, CEO & Director Christopher Quesenberry - GIMOTI’s Chi...
2024-03-14 16:07:20 ET More on Evoke Pharma Evoke Pharma down 28%, prices $30M offering Seeking Alpha’s Quant Rating on Evoke Pharma Historical earnings data for Evoke Pharma Financial information for Evoke Pharma Read the full article on See...
Fiscal year 2023 net product sales from prescriptions totaled approximately $5.2M, a 107% increase from 2022 Company projects $14M in net revenue for 2024 SOLANA BEACH, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialt...
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...
2024-03-13 17:35:32 ET Major earnings expected after the bell on Thursday include: Adobe ( ADBE ) Wheaton Precious Metals Corp. ( WPM ) Ulta Beauty ( ULTA ) Skillz ( SKLZ ) Blink Charging Co. ( BLNK ) Read the full article on Seeking Alpha ...
2024-03-13 17:35:05 ET More on Evoke Pharma Evoke Pharma down 28%, prices $30M offering Seeking Alpha’s Quant Rating on Evoke Pharma Historical earnings data for Evoke Pharma Financial information for Evoke Pharma Read the full article on See...
SOLANA BEACH, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases with an emphasis on Gimoti ® (metoclopramide) nasal spray, today announced that the Company is sche...
SOLANA BEACH, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced today that ...
2024-02-09 07:48:15 ET More on Evoke Pharma Seeking Alpha’s Quant Rating on Evoke Pharma Historical earnings data for Evoke Pharma Financial information for Evoke Pharma Read the full article on Seeking Alpha For further details see: Evoke ...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States Agrify Corporation (AGFY) rose 164.2% to $0.6658 on volume of 125,460,313 shares NVIDIA Corporation (NVDA) fell 2.9% to $122.88 on volume of 51,163,891 shares Crown Electrokinetics Corp. (CRKN) fell 0.3% to $0.04097 on volume of 44,45...
A look at the top 10 most actives in the United States Mustang Bio Inc. (MBIO) rose 141.4% to $0.3138 on volume of 161,736,322 shares ENDRA Life Sciences Inc. (NDRA) rose 13.7% to $0.117778 on volume of 79,058,950 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 27.2% to $0.1042 on volum...
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA BEACH, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK)...